Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
An efficient and highly enantioselective synthesis of tipranavir is realized based on an iridium-catalyzed asymmetric allylic substitution. High yield and diastereoselectivity (>20:1), as well as excellent enantioselectivity (99% ), were obtained for the key intermediate through direct asymmetric alkylation reaction of dihydropyranone with allylic -butyl carbonate. Anti-AIDS drug of tipranavir was finally accomplished in 8 steps and 6 pots starting from commercially available 1-phenyl-3-hexanone in 20.7% overall yield with 99% and >20:1 .
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.orglett.4c03736 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reviewing the Developing Significance of the Serine Protease PRSS23.
Front Biosci (Landmark Ed)
August 2025
Institute of Genomic Medicine Sciences, King Abdulaziz University, 21589 Jeddah, Saudi Arabia.
The serine protease 23 (PRSS23) is a highly conserved member of trypsin-like serine proteases, which are associated with numerous essential processes, including digestion, blood coagulation, fibrinolysis, development, fertilization, apoptosis, and immunity. Original reports on PRSS23 unfolded not earlier than 2006 when a molecular biology study characterized and described PRSS23 as an ovarian protease. Then, in 2012, another important study was published linking PRSS23 with proliferation of breast cancer cells by an estrogen receptor 1 (ESR1)-dependent transcriptional activation of the serine protease.
View Article and Find Full Text PDFSynthesis and antiviral activity of new 4-substituted Oxycoumarins against SARS and HSV-2 viruses: Mechanistic and molecular modeling study.
Bioorg Chem
August 2025
Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
A new series of 4-substituted oxycoumarin scaffolds was designed, synthesized, and evaluated for antiviral activity against both SARS-CoV-2 and HSV-2 viruses. Results indicated that compounds 3a, 4a, 4d, and 6d were found to be the most active members against SARS-CoV-2 with IC values of 11.17-16.
View Article and Find Full Text PDFRepurposing of approved drugs towards Nipah virus treatment: an in silico docking, molecular dynamics simulation and a MM/GBSA approach.
In Silico Pharmacol
June 2025
Department of Chemistry, School of Chemical Sciences, Central University of Karnataka, Kadaganchi, Karnataka 585367 India.
Unlabelled: The Nipah virus (NiV) is an emerging zoonotic pathogen that causes severe febrile encephalitis, transmitted from infected animals to humans. Since its initial outbreak in Malaysia, subsequent epidemics have occurred across Asia, including India, with mortality rates ranging from 40 to 75%. There are no approved vaccines, or antiviral treatments currently exist for NiV infections.
View Article and Find Full Text PDFTipranavir analogs as antiviral agents: Design, synthesis, in vitro, and in silico study of new SARS-CoV-2 main protease inhibitors.
Bioorg Chem
August 2025
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura National University, Gamasa, 7731168, Egypt; Future studies and Risks management' National Committee of Drugs, Academy
The current study aims at developing non-peptidic new antiviral hits against main protease (M) of SARS-COV2 using the non-peptidic M inhibitor tipranavir (TPV) as a starting point. In vitro protease inhibition assay of the targeted compounds indicated that compound 6f and its cyclized triazole analogue 7f were the most active in the present study with IC values of 6.48 and 7.
View Article and Find Full Text PDFRepurposing HIV protease inhibitors as senotherapeutic agents in cervical cancer: Dual targeting of CDK1/6-cell cycle arrest and p53/p21/p16 signaling axis.
Biochem Biophys Res Commun
July 2025
Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, 712100, China; Shenzhen Research Institute, Northwest A&F University, Shenzhen, 518000, China. Electronic address:
The clinical management of cervical cancer remains constrained by limited therapeutic options and a paucity of targeted pharmacological interventions. Drug repurposing emerges as a promising strategy to expedite oncological therapeutics development. This study systematically investigates the antineoplastic potential of HIV protease inhibitors saquinavir (SQV) and tipranavir (TPV) through multimodal mechanistic validation.
View Article and Find Full Text PDF